The present invention relates to a compound having the general formula II, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,which is useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.